Olvanil
CAS No. 58493-49-5
Olvanil ( N-Vanillyloleamide; N-Vannilyloleoylamide )
Catalog No. M27675 CAS No. 58493-49-5
Olvanil is a vanilloid receptor agonist with EC50 of 0.7nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 102 | Get Quote |
|
5MG | 170 | Get Quote |
|
10MG | 250 | Get Quote |
|
25MG | 428 | Get Quote |
|
50MG | 614 | Get Quote |
|
100MG | 853 | Get Quote |
|
500MG | 1692 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameOlvanil
-
NoteResearch use only, not for human use.
-
Brief DescriptionOlvanil is a vanilloid receptor agonist with EC50 of 0.7nM.
-
DescriptionOlvanil is a vanilloid receptor agonist with EC50 of 0.7nM.(In Vitro):Olvanil affects C6 glioma cell proliferation with IC50 of 5.5 μM.(In Vivo):Olvanil is one capsaicin analog. Olvanil acts as an agonist at the vanilloid receptor. Olvanil may have causes an anxiogenic-like effect. Doses of 0, 0.2, 1.0 and 5.0 mg/kg Olvanil, respectively, yielded percent open arm entries at 5 min of 25±10.1, 19.3±7.1, 14.9±5.9 and 0±0.
-
SynonymsN-Vanillyloleamide; N-Vannilyloleoylamide
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorHDAC
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number58493-49-5
-
Formula Weight417.6
-
Molecular FormulaC26H43NO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCCCCCC\C=C/CCCCCCCC(=O)NCc1ccc(O)c(OC)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Han-Li Huang, et al. TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis. Theranostics. 2019 Sep 18;9(22):6676-6689.
molnova catalog
related products
-
Mavatrep
A selective, high-affinity TRPV1 antagonist with IC50 of 4.6 nM (inhibition of capsaicin-induced Ca(2+) influx).
-
JNJ-38893777
JNJ-38893777 is a potent and selective transient receptor potential vanilloid 1 (TRPV1) channel antagonist for treatment of ociceptive and neuropathic pain.
-
GSK2193874
GSK2193874 was identified as a selective orally active TRPV4 blocker.